4AB
AbbVie, Inc. · BSESOF:4AB
264.70 EUR5.00 +1.93%
AbbVie, Inc. (BSESOF:4AB) last traded at 264.70 EUR, up 1.93% on the day. Over the past year the stock is up 34.03%. Its 52-week range is 169.35 to 264.70. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open264.70
Day range264.70 – 264.70
52-week range169.35 – 264.70
Volume0
Average volume (10 days)0
Market cap (USD)521.11 B
P/E51.54
EPS (TTM) (USD)5.82
Dividend yield2.32%
Beta (1 year)−0.7268
Revenue (TTM) (USD)66.01 B
Employees57.00 K
Performance
+4.79%1 week
+13.80%1 month
+21.37%3 months
+55.66%6 months
+39.90%Year to date
+34.03%1 year
Technical rating
Strong buy
Daily summary of 11 oscillators and 15 moving averages. See every indicator
Analysts’ target
271.11 EUR
The average 1-year price target, +2.42% from the last price. See the forecast
Latest headlines
- The top 5 analyst questions from AbbVie’s Q3 earnings callStock Story · 01 Nov 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Key facts: AbbVie, Inc. Q3 revenue $17.404B; Skyrizi approved; lutikizumab successTradingView · 31 Oct 2026
- ABBV Q3 deep dive: Immunology and neuroscience drive growth, pipeline progress continuesStock Story · 31 Oct 2026
- AbbVie Inc. Stock 12‑Month Price Target Raised to $291TradingView · 30 Oct 2026
- LLY, ABBV Stocks Hit All-Time High – Here’s What’s Driving Investor Enthusiasm TodayStocktwits · 30 Oct 2026
- AbbVie Stocks Rise 1.75% With Two Medicines Providing Nearly Half of RevenueGuruFocus · 30 Oct 2026
- What AbbVie (ABBV) Said on Its Q3 Earnings CallMarketBeat · 30 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.